Epilepsy Market Players:
-
- Stryker B.V.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Johnson & Johnson Services, Inc.
- Novartis AG
- Pfizer, Inc.
- Sunovion Pharmaceuticals, Inc.
- Sanofi aventis Group
- Koninklijke Philips N.V.
- Eisai Co. Ltd.
- Cephalon, Inc.
- Abbott Laboratories
- Stryker B.V.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of the epilepsy was over USD 2.69 billion.
The global epilepsy market size was USD 2.69 billion in 2026 and is likely to reach USD 4.3 billion by the end of 2036, expanding at a CAGR of 4.8% over the forecast period, i.e., 2027-2036.
North America epilepsy market will hold around 39.5% share by 2036, driven by the increasing prevalence of epilepsy, with over 1.2% of the US population affected, supported by a strong healthcare network.
Key players in the market include Stryker B.V., Johnson & Johnson Services, Inc., Novartis AG, Pfizer, Inc., Sunovion Pharmaceuticals, Inc., Sanofi aventis Group, Koninklijke Philips N.V., Eisai Co. Ltd., Cephalon, Inc., Abbott Laboratories.
